U. Matulonis

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Rocio García‐Carbonero, Jeff Supko, Judith Manola et al. · Journal of Clinical Oncology · 2004 · 293 citations · Full text

Medicine, Oncology, Pharmacology +13

Role of B7-1 in mediating an immune response to myeloid leukemia cells

U. Matulonis, Chrysoula Dosiou, Christine Lamont et al. · Blood · 1995 · 117 citations · Full text

Life Sciences, Immunology, Oncology +10

Bevacizumab in patients with advanced platinum-resistant ovarian cancer

S A Cannistra, U. Matulonis, Richard T. Penson et al. · Journal of Clinical Oncology · 2006 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +16

Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

Jonathan A. Ledermann, Philipp Harter, C. Gourley et al. · Journal of Clinical Oncology · 2011 · 58 citations

Medicine, Oncology, Pharmacology +14

A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.

R. T. Penson, Charles J. Whalen, Brian Lasonde et al. · Journal of Clinical Oncology · 2011 · 33 citations

Medicine, Oncology, Pharmacology +17